Insider · CIK 0001252524

Emster Kurt VON

CIK 0001252524 Name as filed on the most recent filing

Filed as Emster Kurt VON (60)

97 transaction lines · from 60 filings · filed 2004-02-23 to 2023-09-29 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

96 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2017-08-28 S, Open-market sale Crispr Therapeutics AGCRSP 1,741,738, disposed Open Form 4 filing 0000905718-17-000815
2017-08-25 S, Open-market sale Crispr Therapeutics AGCRSP 291,102, disposed Open Form 4 filing 0000905718-17-000813
2017-08-24 S, Open-market sale Crispr Therapeutics AGCRSP 151,302, disposed Open Form 4 filing 0000905718-17-000813
2017-08-23 S, Open-market sale Crispr Therapeutics AGCRSP 130,359, disposed Open Form 4 filing 0000905718-17-000808
2017-08-22 S, Open-market sale Crispr Therapeutics AGCRSP 202,978, disposed Open Form 4 filing 0000905718-17-000808
2017-08-21 S, Open-market sale Crispr Therapeutics AGCRSP 23,138, disposed Open Form 4 filing 0000905718-17-000804
2017-08-18 S, Open-market sale Crispr Therapeutics AGCRSP 35,207, disposed Open Form 4 filing 0000905718-17-000804
2017-08-17 S, Open-market sale Crispr Therapeutics AGCRSP 254,733, disposed Open Form 4 filing 0000905718-17-000794
2017-08-16 S, Open-market sale Crispr Therapeutics AGCRSP 395,960, disposed Open Form 4 filing 0000905718-17-000794
2017-08-15 S, Open-market sale Crispr Therapeutics AGCRSP 499,695, disposed Open Form 4 filing 0000905718-17-000788
2017-08-14 S, Open-market sale Crispr Therapeutics AGCRSP 588,866, disposed Open Form 4 filing 0000905718-17-000788
2017-08-08 S, Open-market sale Crispr Therapeutics AGCRSP 371,394, disposed Open Form 4 filing 0000905718-17-000753
2017-08-07 S, Open-market sale Crispr Therapeutics AGCRSP 289,494, disposed Open Form 4 filing 0000905718-17-000753
2017-08-04 S, Open-market sale Crispr Therapeutics AGCRSP 56,758, disposed Open Form 4 filing 0000905718-17-000749
2017-08-03 S, Open-market sale Crispr Therapeutics AGCRSP 842,458, disposed Open Form 4 filing 0000905718-17-000749
2017-08-01 S, Open-market sale Crispr Therapeutics AGCRSP 4,620, disposed Open Form 4 filing 0000905718-17-000745
2017-07-31 S, Open-market sale Crispr Therapeutics AGCRSP 91,871, disposed Open Form 4 filing 0000905718-17-000745
2017-07-28 S, Open-market sale Crispr Therapeutics AGCRSP 7,060, disposed Open Form 4 filing 0000905718-17-000737
2017-07-27 S, Open-market sale Crispr Therapeutics AGCRSP 721,074, disposed Open Form 4 filing 0000905718-17-000737
2017-07-26 S, Open-market sale Crispr Therapeutics AGCRSP 418,607, disposed Open Form 4 filing 0000905718-17-000732
2017-07-25 S, Open-market sale Crispr Therapeutics AGCRSP 160,939, disposed Open Form 4 filing 0000905718-17-000732
2017-07-19 P, Open-market purchase CymaBay Therapeutics, Inc.CBAY 999,999, acquired Open Form 4 filing 0000905718-18-000123
2017-07-14 S, Open-market sale Crispr Therapeutics AGCRSP 609,389, disposed Open Form 4 filing 0000905718-17-000706
2017-07-13 S, Open-market sale Crispr Therapeutics AGCRSP 567,321, disposed Open Form 4 filing 0000905718-17-000706
2017-07-12 S, Open-market sale Crispr Therapeutics AGCRSP 296,675, disposed Open Form 4 filing 0000905718-17-000670
2017-07-11 S, Open-market sale Crispr Therapeutics AGCRSP 233,262, disposed Open Form 4 filing 0000905718-17-000670
2017-07-05 S, Open-market sale Crispr Therapeutics AGCRSP 69,170, disposed Open Form 4 filing 0000905718-17-000657
2017-06-29 S, Open-market sale Crispr Therapeutics AGCRSP 191,797, disposed Open Form 4 filing 0000905718-17-000644
2017-06-28 S, Open-market sale Crispr Therapeutics AGCRSP 538,328, disposed Open Form 4 filing 0000905718-17-000644
2017-06-27 S, Open-market sale Crispr Therapeutics AGCRSP 582,755, disposed Open Form 4 filing 0000905718-17-000636
2017-06-26 S, Open-market sale Crispr Therapeutics AGCRSP 807,857, disposed Open Form 4 filing 0000905718-17-000636
2017-06-23 S, Open-market sale Crispr Therapeutics AGCRSP 500,549, disposed Open Form 4 filing 0000905718-17-000626
2017-06-22 S, Open-market sale Crispr Therapeutics AGCRSP 24,753, disposed Open Form 4 filing 0000905718-17-000626
2016-10-24 P, Open-market purchase Crispr Therapeutics AGCRSP 784,000, acquired Open Form 4 filing 0000899243-17-003618
2012-09-05 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 396, disposed Open Form 4 filing 0001209191-12-044584
2010-12-02 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 72,301, disposed Open Form 4 filing 0001209191-10-058425
2010-04-30 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 319,148, disposed Open Form 4 filing 0001209191-10-025087
2009-07-08 P, Open-market purchase Somaxon Pharmaceuticals, Inc.SOMX 44,681, acquired Open Form 4 filing 0001209191-09-036473
2007-05-14 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 537,403, disposed Open Form 4 filing 0001209191-07-030722
2007-05-11 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 468,865, disposed Open Form 4 filing 0001209191-07-029960
2007-05-10 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 391,325, disposed Open Form 4 filing 0001209191-07-029960
2006-09-11 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 4 lines 43,290, disposed Open Form 4 filing 0001209191-06-049943
2005-12-20 P, Open-market purchase Somaxon Pharmaceuticals, Inc.SOMX 2,002,000, acquired Open Form 4 filing 0001209191-05-064658
2004-02-19 S, Open-market sale Rigel Pharmaceuticals IncRIGL 3,447,460, disposed Open Form 4 filing 0001209191-04-012147

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 8
  • Open-market sale 88
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. EMSTER KURT VON, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001252524

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.